These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Price type key:
Federal Supply Schedule (FSS): generally available to all Federal Govt agencies /
'BIG4' prices: VA, DoD, Public Health & Coast Guard only /
National Contracts (NC): Available to specific agencies
60687-0776 Market Analysis and Financial Projection
The drug associated with NDC 60687-0776 (11-digit format: 60687-0776-01) is Amoxicillin, an antibiotic used to treat bacterial infections. Below is a market analysis and price projection for Amoxicillin:
Market Overview
Current Market Size
The global Amoxicillin market was valued at $4.8 billion in 2022[16] and is projected to grow at a CAGR of 1.2–2%, reaching $5.3–5.51 billion by 2030[14][16].
The Amoxicillin API (Active Pharmaceutical Ingredient) market is expected to expand further, reaching $1.5 billion by 2025 with a 5% CAGR through 2033[9], driven by demand in human and veterinary applications.
Growth Drivers
Rising Bacterial Infections: Increasing prevalence of pneumonia, urinary tract infections, and respiratory illnesses, especially in Asia-Pacific[14].
Generic Accessibility: Cost-effective generic formulations dominate the market, ensuring affordability[9][15].
Veterinary Use: Growing demand in livestock farming for infection management[9].
Regulatory Approvals: Expanded indications, such as Helicobacter pylori eradication and respiratory infections[14][15].
Challenges
Antibiotic Resistance: Overuse has led to reduced efficacy, driving the need for novel formulations[9][14].
Supply Chain Volatility: Production disruptions (e.g., raw material shortages, geopolitical tensions) affect pricing stability[13][14].
Regional Insights
Asia-Pacific: Accounts for 36.8% of the 6-Aminopenicillanic Acid (6-APA, a key Amoxicillin precursor) market[12], driven by high infection rates and healthcare investments in India and China[9][14].
North America: Second-largest market due to advanced healthcare infrastructure and rising antibiotic prescriptions[14][15].
Price Trends
2024 Outlook:
North America: Prices rose in H1 2024 due to strong pharmaceutical demand and supply chain disruptions (e.g., Baltimore bridge collapse)[13]. Analysts project a bullish trend into 2025 with continued supply challenges[13].
Asia: Prices fluctuated with production constraints and port congestion, ending Q2 2024 on an upward trajectory[13].
Europe: Gradual price increases due to logistical hurdles and export demand[13].
Long-Term Projections
Prices are expected to stabilize with moderate annual increases (1–3%) due to generic competition and improved production efficiency[13][14].
Competitive Landscape
Key players include Teva Pharmaceutical, Novartis, Pfizer, and Mylan, focusing on API innovation and sustainable manufacturing methods[12][14].
Key Takeaways
Amoxicillin remains a cornerstone antibiotic with steady demand.
While market growth is modest (1.2–5% CAGR), price volatility persists due to supply chain dynamics.
Asia-Pacific will lead growth, while North America and Europe face cost pressures from regulatory and logistical challenges[9][13][14].
“Amoxicillin should remain the first-line antibiotic for treating bacterial infections, but addressing resistance and supply bottlenecks is critical.” – IndustryARC Analysis[16]
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
